Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Development (Cambridge, England)|March 31, 2017
Regulation of <i>Brn3b</i> by DLX1 and DLX2 is required for retinal ganglion cell differentiation in the vertebrate retinaQi Zhang, Jamie Zagozewski, Shaohong Cheng, et al.
Journal of Paediatrics and Child Health|June 11, 2021
Growth hormone and targeted oncological agents: Are we stopping children with brain tumours from reaching their true height potential?Hannah Walker, Dong Anh Khuong Quang, Martin Campbell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE studyJames R Perry, Karl Bélanger, Warren P Mason, et al.
Neuro-Oncology Advances|May 8, 2023
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine gliomaStacie S Wang, Alexander J Davenport, Melinda Iliopoulos, et al.
Journal of Neuro-Oncology|May 14, 2015
Low grade astrocytoma in children under the age of three years: a report from the Canadian pediatric brain tumour consortiumDonna L Johnston, Daniel Keene, Ute Bartels, et al.
Nucleic Acids Research|February 23, 2021
Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradationH Helena Wu, Benfan Wang, Stephen R Armstrong, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 22, 2011
Spinal cord tumors in children under the age of 3 years: a retrospective Canadian reviewShayna Zelcer, Daniel Keene, Ute Bartels, et al.
Journal of Neuro-Oncology|February 3, 2009
Medulloblastoma in children under the age of three years: a retrospective Canadian reviewDonna L Johnston, Daniel Keene, Ute Bartels, et al.
Pageof 9